RecallDepth
Class II Terminated

Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018-3524 USA, API from SPAIN, NDC 0264-9587-20.

This recall has been terminated (originally issued June 19, 2019).

Company
B. Braun Medical Inc
Recall Initiated
June 13, 2019
Posted
June 19, 2019
Recall Number
D-1343-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
40,176 bags
Firm Location
Irvine, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: J7B259, Exp 31 Aug 2019

More recalls by B. Braun Medical Inc

View all recalls by this company →

Other recent Class II Drug recalls